GLOBALE SOLUTION BIOLOGIE & IMAGERIE MEDICALE : revenue, balance sheet and financial ratios

GLOBALE SOLUTION BIOLOGIE & IMAGERIE MEDICALE is a French company founded 28 years ago, specialized in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques. Based in CAYENNE (97300), this company of category PME shows in 2022 a revenue of 2.3 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - GLOBALE SOLUTION BIOLOGIE & IMAGERIE MEDICALE (SIREN 412908881)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue N/C N/C 2 290 507 € 2 808 286 € 2 585 375 € 2 063 078 € 1 867 875 € 1 889 426 € 2 650 874 €
Net income 275 360 € 268 702 € 465 247 € 633 757 € 494 782 € 144 321 € 248 547 € 359 672 € 737 909 €
EBITDA N/C N/C 878 741 € 696 086 € 825 264 € 282 582 € 391 000 € 671 667 € 1 113 696 €
Net margin N/C N/C 20.3% 22.6% 19.1% 7.0% 13.3% 19.0% 27.8%

Revenue and income statement

In 2024, GLOBALE SOLUTION BIOLOGIE & IMAGERIE MEDICALE generates positive net income of 275 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 738 k€ -> 275 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

275 360 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 1%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 96%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

1.108%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

95.722%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

3.7%

Solvency indicators evolution
GLOBALE SOLUTION BIOLOGIE & IMAGERIE MEDICALE

Sector positioning

Debt ratio
1.11 2024
2022
2023
2024
Q1: 0.0
Med: 4.27
Q3: 43.96
Good

In 2024, the debt ratio of GLOBALE SOLUTION BIOLOGIE... (1.11) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
95.72% 2024
2022
2023
2024
Q1: 14.64%
Med: 38.36%
Q3: 60.56%
Excellent +20 pts over 3 years

In 2024, the financial autonomy of GLOBALE SOLUTION BIOLOGIE... (95.7%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Repayment capacity
0.36 years 2022
2022
Q1: 0.0 years
Med: 0.01 years
Q3: 1.6 years
Average

In 2022, the repayment capacity of GLOBALE SOLUTION BIOLOGIE... (0.36) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 2613.26. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

2613.263

Liquidity indicators evolution
GLOBALE SOLUTION BIOLOGIE & IMAGERIE MEDICALE

Sector positioning

Liquidity ratio
2613.26 2024
2022
2023
2024
Q1: 132.74
Med: 202.27
Q3: 325.9
Excellent

In 2024, the liquidity ratio of GLOBALE SOLUTION BIOLOGIE... (2613.26) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Interest coverage
1.15x 2022
2022
Q1: 0.0x
Med: 0.34x
Q3: 4.26x
Good

In 2022, the interest coverage of GLOBALE SOLUTION BIOLOGIE... (1.1x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
GLOBALE SOLUTION BIOLOGIE & IMAGERIE MEDICALE

Positioning of GLOBALE SOLUTION BIOLOGIE & IMAGERIE MEDICALE in its sector

Comparison with sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Valuation estimate

Based on 124 transactions of similar company sales (all years), the value of GLOBALE SOLUTION BIOLOGIE & IMAGERIE MEDICALE is estimated at 226 212 € (range 86 098€ - 826 099€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
124 transactions
86k€ 226k€ 826k€
226 212 € Range: 86 098€ - 826 099€
NAF 5 all-time

Valuation method used

Net Income Multiple
275 360 € × 0.8x = 226 213 €
Range: 86 098€ - 826 100€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 124 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de gros (commerce interentreprises) de produits pharmaceutiques)

Compare GLOBALE SOLUTION BIOLOGIE & IMAGERIE MEDICALE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Frequently asked questions about GLOBALE SOLUTION BIOLOGIE & IMAGERIE MEDICALE

What is the revenue of GLOBALE SOLUTION BIOLOGIE & IMAGERIE MEDICALE ?

The revenue of GLOBALE SOLUTION BIOLOGIE & IMAGERIE MEDICALE in 2022 is 2.3 M€.

Is GLOBALE SOLUTION BIOLOGIE & IMAGERIE MEDICALE profitable?

Yes, GLOBALE SOLUTION BIOLOGIE & IMAGERIE MEDICALE generated a net profit of 275 k€ in 2024.

Where is the headquarters of GLOBALE SOLUTION BIOLOGIE & IMAGERIE MEDICALE ?

The headquarters of GLOBALE SOLUTION BIOLOGIE & IMAGERIE MEDICALE is located in CAYENNE (97300), in the department Guyane.

Where to find the tax return of GLOBALE SOLUTION BIOLOGIE & IMAGERIE MEDICALE ?

The tax return of GLOBALE SOLUTION BIOLOGIE & IMAGERIE MEDICALE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does GLOBALE SOLUTION BIOLOGIE & IMAGERIE MEDICALE operate?

GLOBALE SOLUTION BIOLOGIE & IMAGERIE MEDICALE operates in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques (NAF code 46.46Z). See the 'Sector positioning' section above to compare the company with its competitors.